Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds

Detalhes bibliográficos
Autor(a) principal: Almeida, Mirella Hansen de
Data de Publicação: 2013
Outros Autores: Dantas, Joana Rodrigues, Barone, Bianca, Serfaty, Fabiano Marcel, Kupfer, Rosane, Albernaz, Marta, Bencke, Maria Rocio, Zajdenverg, Lenita, Rodacki, Melanie, Oliveira, José Egídio Paulo de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/52330
Resumo: OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diabetes and variable disease durations. METHOD: Eighty-eight patients with a mean disease duration of 8.1 +7.6 years were included and underwent C-peptide measurement before and after glucagon stimulation. Chi-squared and Mann Whitney U-tests were used to compare the variables between groups (all two-tailed, a = 0.05). Spearmans correlation coefficient was used to test the association between the continuous variables. Logistic regression was used for the multivariate analysis. Twenty-eight (31.8%) individuals had significantly detectable C-peptide levels after stimuli, particularly those with a shorter disease duration (p
id USP-19_5141b84b23fbbbe142a09f654b1ebce2
oai_identifier_str oai:revistas.usp.br:article/52330
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds Diabetes Mellitus Type-1C-PeptideInsulin SecretionDisease DurationGADAAutoimmune Disease OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diabetes and variable disease durations. METHOD: Eighty-eight patients with a mean disease duration of 8.1 +7.6 years were included and underwent C-peptide measurement before and after glucagon stimulation. Chi-squared and Mann Whitney U-tests were used to compare the variables between groups (all two-tailed, a = 0.05). Spearmans correlation coefficient was used to test the association between the continuous variables. Logistic regression was used for the multivariate analysis. Twenty-eight (31.8%) individuals had significantly detectable C-peptide levels after stimuli, particularly those with a shorter disease duration (pHospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/5233010.6061/clinics/2013(01)RC02Clinics; Vol. 68 No. 1 (2013); 123-126 Clinics; v. 68 n. 1 (2013); 123-126 Clinics; Vol. 68 Núm. 1 (2013); 123-126 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/52330/56357Almeida, Mirella Hansen deDantas, Joana RodriguesBarone, BiancaSerfaty, Fabiano MarcelKupfer, RosaneAlbernaz, MartaBencke, Maria RocioZajdenverg, LenitaRodacki, MelanieOliveira, José Egídio Paulo deinfo:eu-repo/semantics/openAccess2013-03-09T14:08:18Zoai:revistas.usp.br:article/52330Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2013-03-09T14:08:18Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
title Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
spellingShingle Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
Almeida, Mirella Hansen de
Diabetes Mellitus Type-1
C-Peptide
Insulin Secretion
Disease Duration
GADA
Autoimmune Disease
title_short Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
title_full Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
title_fullStr Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
title_full_unstemmed Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
title_sort Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
author Almeida, Mirella Hansen de
author_facet Almeida, Mirella Hansen de
Dantas, Joana Rodrigues
Barone, Bianca
Serfaty, Fabiano Marcel
Kupfer, Rosane
Albernaz, Marta
Bencke, Maria Rocio
Zajdenverg, Lenita
Rodacki, Melanie
Oliveira, José Egídio Paulo de
author_role author
author2 Dantas, Joana Rodrigues
Barone, Bianca
Serfaty, Fabiano Marcel
Kupfer, Rosane
Albernaz, Marta
Bencke, Maria Rocio
Zajdenverg, Lenita
Rodacki, Melanie
Oliveira, José Egídio Paulo de
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Almeida, Mirella Hansen de
Dantas, Joana Rodrigues
Barone, Bianca
Serfaty, Fabiano Marcel
Kupfer, Rosane
Albernaz, Marta
Bencke, Maria Rocio
Zajdenverg, Lenita
Rodacki, Melanie
Oliveira, José Egídio Paulo de
dc.subject.por.fl_str_mv Diabetes Mellitus Type-1
C-Peptide
Insulin Secretion
Disease Duration
GADA
Autoimmune Disease
topic Diabetes Mellitus Type-1
C-Peptide
Insulin Secretion
Disease Duration
GADA
Autoimmune Disease
description OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diabetes and variable disease durations. METHOD: Eighty-eight patients with a mean disease duration of 8.1 +7.6 years were included and underwent C-peptide measurement before and after glucagon stimulation. Chi-squared and Mann Whitney U-tests were used to compare the variables between groups (all two-tailed, a = 0.05). Spearmans correlation coefficient was used to test the association between the continuous variables. Logistic regression was used for the multivariate analysis. Twenty-eight (31.8%) individuals had significantly detectable C-peptide levels after stimuli, particularly those with a shorter disease duration (p
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/52330
10.6061/clinics/2013(01)RC02
url https://www.revistas.usp.br/clinics/article/view/52330
identifier_str_mv 10.6061/clinics/2013(01)RC02
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/52330/56357
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 68 No. 1 (2013); 123-126
Clinics; v. 68 n. 1 (2013); 123-126
Clinics; Vol. 68 Núm. 1 (2013); 123-126
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222759709573120